Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1347 | 7852 | 42.6 | 79% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1651 | 2472 | MOL RECOGNIT SECT//A3 ADENOSINE RECEPTOR//ADENOSINE RECEPTORS |
2906 | 2039 | PROPENTOFYLLINE//ADENOSINE A1 RECEPTOR//A1 RECEPTOR |
5261 | 1581 | ADENOSINE A2A RECEPTOR//ADENOSINE A2A RECEPTORS//ISTRADEFYLLINE |
6783 | 1368 | NEW ENGLAND INFLAMMAT TISSUE PROTECT//MUCOSAL INFLAMMAT PROGRAM//ADENOSINE RECEPTORS |
26413 | 210 | GUANOSINE//NEOTROFIN//AIT 082 |
27732 | 182 | HUMAN PLACENTAL EXTRACT//PLACENTA EXTRACT//PORCINE PLACENTA EXTRACT |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ADENOSINE | Author keyword | 323 | 22% | 17% | 1308 |
2 | ADENOSINE RECEPTORS | Author keyword | 312 | 53% | 5% | 415 |
3 | ADENOSINE A2A RECEPTOR | Author keyword | 236 | 67% | 3% | 213 |
4 | ADENOSINE RECEPTOR | Author keyword | 183 | 49% | 4% | 275 |
5 | MOL RECOGNIT SECT | Address | 125 | 52% | 2% | 170 |
6 | ADENOSINE A1 RECEPTOR | Author keyword | 110 | 50% | 2% | 157 |
7 | A2A RECEPTOR | Author keyword | 83 | 66% | 1% | 77 |
8 | CGS 21680 | Author keyword | 81 | 74% | 1% | 60 |
9 | IB MECA | Author keyword | 73 | 96% | 0% | 23 |
10 | ADENOSINE A2A RECEPTORS | Author keyword | 72 | 67% | 1% | 65 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENOSINE | 323 | 22% | 17% | 1308 | Search ADENOSINE | Search ADENOSINE |
2 | ADENOSINE RECEPTORS | 312 | 53% | 5% | 415 | Search ADENOSINE+RECEPTORS | Search ADENOSINE+RECEPTORS |
3 | ADENOSINE A2A RECEPTOR | 236 | 67% | 3% | 213 | Search ADENOSINE+A2A+RECEPTOR | Search ADENOSINE+A2A+RECEPTOR |
4 | ADENOSINE RECEPTOR | 183 | 49% | 4% | 275 | Search ADENOSINE+RECEPTOR | Search ADENOSINE+RECEPTOR |
5 | ADENOSINE A1 RECEPTOR | 110 | 50% | 2% | 157 | Search ADENOSINE+A1+RECEPTOR | Search ADENOSINE+A1+RECEPTOR |
6 | A2A RECEPTOR | 83 | 66% | 1% | 77 | Search A2A+RECEPTOR | Search A2A+RECEPTOR |
7 | CGS 21680 | 81 | 74% | 1% | 60 | Search CGS+21680 | Search CGS+21680 |
8 | IB MECA | 73 | 96% | 0% | 23 | Search IB+MECA | Search IB+MECA |
9 | ADENOSINE A2A RECEPTORS | 72 | 67% | 1% | 65 | Search ADENOSINE+A2A+RECEPTORS | Search ADENOSINE+A2A+RECEPTORS |
10 | ADENOSINE A3 RECEPTOR | 72 | 70% | 1% | 59 | Search ADENOSINE+A3+RECEPTOR | Search ADENOSINE+A3+RECEPTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | A2A RECEPTORS | 261 | 63% | 3% | 263 |
2 | H 3 CGS 21680 | 161 | 92% | 1% | 65 |
3 | A3 RECEPTOR | 156 | 73% | 2% | 118 |
4 | ENDOGENOUS ADENOSINE | 129 | 44% | 3% | 221 |
5 | CGS 21680 | 123 | 83% | 1% | 69 |
6 | 2 AMINO 3 BENZOYLTHIOPHENES | 121 | 90% | 1% | 53 |
7 | A3 RECEPTORS | 118 | 65% | 1% | 113 |
8 | ADENOSINE A1 RECEPTOR BINDING | 105 | 88% | 1% | 50 |
9 | AGONIST H 3 CGS 21680 | 102 | 95% | 0% | 35 |
10 | A1 RECEPTOR | 102 | 53% | 2% | 134 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PURINERGIC SIGNALLING | 12 | 17% | 1% | 62 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors | 2001 | 1507 | 326 | 71% |
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update | 2011 | 250 | 264 | 68% |
Adenosine receptors as therapeutic targets | 2006 | 634 | 194 | 72% |
Adenosine receptors as drug targets - what are the challenges? | 2013 | 84 | 278 | 63% |
The A(3) Adenosine Receptor: History and Perspectives | 2015 | 3 | 350 | 79% |
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases | 2008 | 349 | 123 | 76% |
Adenosine: an endogenous regulator of innate immunity | 2004 | 410 | 60 | 80% |
The role and regulation of adenosine in the central nervous system | 2001 | 779 | 148 | 58% |
Adenosine, an endogenous distress signal, modulates tissue damage and repair | 2007 | 278 | 70 | 61% |
NOMENCLATURE AND CLASSIFICATION OF PURINOCEPTORS | 1994 | 1323 | 111 | 44% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL RECOGNIT SECT | 125 | 52% | 2.2% | 170 |
2 | NEW ENGLAND INFLAMMAT TISSUE PROTECT | 33 | 67% | 0.4% | 29 |
3 | SECT MOL NEUROPHARMACOL | 30 | 60% | 0.4% | 32 |
4 | MUCOSAL INFLAMMAT PROGRAM | 27 | 38% | 0.7% | 55 |
5 | DRUG PHARMACOL SCI | 21 | 75% | 0.2% | 15 |
6 | NEUROSCI COIMBRA | 14 | 29% | 0.5% | 41 |
7 | ROBERT STONE DOW NEUROBIOL S | 13 | 55% | 0.2% | 16 |
8 | SEZ FARMACOL | 12 | 21% | 0.7% | 52 |
9 | MOL MODELING SECT | 11 | 36% | 0.3% | 26 |
10 | RS DOW NEUROBIOL S | 9 | 48% | 0.2% | 14 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000026614 | P2X7 RECEPTOR//P2X7//NTPDASE |
2 | 0.0000014326 | DEOXYCYTIDINE KINASE//PURINE NUCLEOSIDE PHOSPHORYLASE//NUCLEOSIDE TRANSPORT |
3 | 0.0000012668 | CAFFEINE//COFFEE//ENERGY DRINKS |
4 | 0.0000010102 | RGS PROTEINS//G PROTEIN COUPLED RECEPTOR//RGS |
5 | 0.0000007719 | POSTCONDITIONING//ISCHEMIC PRECONDITIONING//NICORANDIL |
6 | 0.0000007278 | KINDLING//ABSENCE EPILEPSY//EPILEPSY RESEARCH |
7 | 0.0000007164 | CATHETER ABLATION//ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA//ATRIAL FLUTTER |
8 | 0.0000007163 | CHLOROETHYLCLONIDINE//ALPHA1 ADRENOCEPTOR SUBTYPE//BETA3 ADRENOCEPTORS |
9 | 0.0000005938 | CEREBRAL ISCHEMIA//SPREADING DEPRESSION//ISCHEMIC TOLERANCE |
10 | 0.0000005514 | TUBULOGLOMERULAR FEEDBACK//SALT SENSITIVITY//AFFERENT ARTERIOLE |